This little Crispr went to market
Gene editing technology heading towards commercial reality in pharmaceuticals, food and organ transplant
In recent years, Crispr-Cas9 gene editing has made many headlines, with stories about its ability to make precise gene edits alongside tales of hotly contested patent battles. But the field is now moving on, with a multitude of start-up companies looking to use Crispr’s ‘molecular scissors’ to make commercial products.
Unsurprisingly, much of the interest is in pharmaceuticals, but there are also application in growing organs for transplant and modifying food crops.